Green tea ovarian cancer research shows up to 77% reduced risk*
Several studies have shown that women who drink green tea daily have a reduced risk of developing ovarian cancer.
*The case-control study compared 254 women with ovarian cancer with 652 controls.
Women who drank green tea daily showed 61% reduced risk of ovarian cancer.
Women who had been drinking green tea every day for over 30 years showed 77% reduced risk of ovarian cancer (Zhang M, Tea consumption and ovarian cancer risk: a case-control study in China, Cancer Epidemiology, Biomarkers, & Prevention, August 2002).
Survival was significantly higher for the tea drinkers:
77.9% of the women who drank tea survived three years,
while only 47.9% of the non-tea drinkers survived (Zhang M, Green tea consumption enhances survival of epithelial ovarian cancer, International Journal of Cancer, November 2004).
781 women from Washington state were compared to 1263 controls.
Researchers found no associations between ovarian cancer risk and coffee, decaffeinated coffee, colas, herbal tea, or black tea.
However, there was a significant reduction in ovarian cancer risk of 54% among women who drank at least one cup of green tea daily.
This green tea ovarian cancer risk reduction was the same for both invasive and borderline ovarian cancer cases.
It was the same even when Asian women were excluded from the analysis (Song YJ, Coffee, tea, colas, and risk of epithelial ovarian cancer, Cancer Epidemiology, Biomarkers & Prevention. March 2008).
Green tea ovarian cancer studies explain green tea protection
EGCG also reduced angiogenesis, vascular endothelial growth factor, and tumor proteinase activation. Through these activities, tumor growth was significantly inhibited (Spinella F, Green tea polyphenol epigallocatechin-3-gallate inhibits the endothelin axis and downstream signaling pathways in ovarian carcinoma. Molecular Cancer Therapeutics, June 2006).
Another green tea ovarian cancer study by Spinella with the same two ovarian cancer cell lines found that EGCG significantly reduced the COX-1/2-derived prostaglandin E2 (PGE2) production (Spinella F, Antitumor effect of green tea polyphenol epigallocatechin-3-gallate in ovarian carcinoma cells: evidence for the endothelin-1 as a potential target, Experimental Biology and Medicine, June 2006).
EGCG inhibited all cell lines by 50% while EC only inhibited one cell line by 50%.
However, ECG from green tea was more effective than EGCG from green tea at lower concentrations (Ravindranath MH, Epicatechins Purified from Green Tea (Camellia sinensis) Differentially Suppress Growth of Gender-Dependent Human Cancer Cell Lines, Evidence-based Complementary and Alternative Medicine, June 2006).
In other words, the more EGCG, the more cancer reduction.
This green tea ovarian cancer study showed that EGCG arrested the cancer cell cycle, modified gene and protein expression to reduce cancer growth, and increased apoptosis or cancer cell death (Huh SW, Anticancer effects of (-)-epigallocatechin-3-gallate on ovarian carcinoma cell lines, Gynecologic Oncology, September 2004).
They found that EGCG slowed the growth of the cancer cells and increased the apoptosis or death of the cells.
They also found that EGCG down-regulated AQP5 (aquaporin 5) which is associated with metastasis, infiltration, and angiogenesis for ovarian cancer.
Again, the results were dose and time dependent.
The more EGCG, and the longer the application, the greater the effects on the cancer cells (Yan C et al, Inhibitory effect of Epigallocatechin gallate on ovarian cancer cell proliferation associated with aquaporin 5 expression, Arch Gynecol Obstet, June 23, 2011).
It kills cancer cells through apoptosis and may improve the effects of cisplatin used in chemotherapy.
Human studies showed decreased occurrence and better outcomes with green tea (Trudel D et al, Green tea for ovarian cancer prevention and treatment: a systematic review of the in vitro, in vivo and epidemiological studies, Gynecologic Oncology, 2012 May 4).
Learn more to live longer
The rate of ovarian cancer in the United States has held almost steady for over 30 years.
In 2008, the American Cancer Society estimates 21,650 new cases of ovarian cancer and 15,520 women dying from ovarian cancer annually.
While early detection at early stage cancer improves women's survival rate up to 95%, at least 75% of women are not diagnosed with ovarian cancer until later stages (CDC). Please check with your doctor for your personal risk level and appropriate diagnostic tests.
Depending on your health condition, you may want to consider developing the healthy habit of daily green tea.
Knowledge is one of our greatest weapons against disease.
More health info with free subscription to the Green Tea Health Newsletter here:
This page last updated by Sharon Jones.
Subscribe now and don't miss a single issue.
Find out more!